Health
Survey: 1 in 8 U.S. Adults Has Used GLP-1 Drugs Like Ozempic
Recent data from a KFF Health Tracking Poll indicates that approximately 12% of U.S. adults have used a GLP-1 agonist, a class of drugs that includes Wegovy, Ozempic, Zepbound, and Mounjaro. While these medications are often prescribed for weight loss, they are also commonly used to manage diabetes and